KKR closing on $5bn pharma exit
KKR is close to selling capsule maker Capsugel to Swiss drug maker Lonza for more than $5bn.
Home Private Equity News & Analysis Private Equity Deals & Transactions KKR closing on $5bn pharma exit
KKR is close to selling capsule maker Capsugel to Swiss drug maker Lonza for more than $5bn.
Copyright PEI Media
Not for publication, email or dissemination